Annual report

Period2025-01-01 → 2025-12-31
Filed2026-03-26
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 149
MetricValuePeriodScopeSource row
Revenue¥2.47T2025-01-01 → 2025-12-31Cons.Revenue IFRS
Revenue¥2.33T2024-01-01 → 2024-12-31Cons.Revenue IFRS
Revenue¥2.02T2023-01-01 → 2023-12-31vCons.Revenue IFRS (5-year summary)
Revenue¥1.74T2022-01-01 → 2022-12-31vCons.Revenue IFRS (5-year summary)
Revenue¥1.50T2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥479.4bn2025-01-01 → 2025-12-31Cons.Operating profit loss IFRS
Operating income¥323.6bn2024-01-01 → 2024-12-31Cons.Operating profit loss IFRS
Profit before tax¥468.0bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS
Profit before tax¥335.9bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS
Profit before tax¥142.7bn2023-01-01 → 2023-12-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥173.0bn2022-01-01 → 2022-12-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥163.6bn2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥363.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥343.1bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥121.6bn2023-01-01 → 2023-12-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥133.9bn2022-01-01 → 2022-12-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥125.5bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥366.2bn2025-01-01 → 2025-12-31Cons.Profit loss IFRS
Net income¥347.3bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS
Total assets¥4.20Tat 2025-12-31Cons.Assets IFRS
Total assets¥3.74Tat 2024-12-31Cons.Assets IFRS
Total assets¥3.36Tat 2023-12-31vCons.Total assets IFRS (5-year summary)
Total assets¥3.10Tat 2022-12-31vCons.Total assets IFRS (5-year summary)
Total assets¥2.82Tat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥1.10Tat 2025-12-31Cons.Liabilities IFRS
Total liabilities¥961.1bnat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥3.10Tat 2025-12-31Cons.Equity IFRS
Net assets / equity¥2.78Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥2.44Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥3.03Tat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.73Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.39Tat 2023-12-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.23Tat 2022-12-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.01Tat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥534.6bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥426.2bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥513.3bnat 2023-12-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥471.6bnat 2022-12-31vCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥410.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥403.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥354.6bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥283.2bn2023-01-01 → 2023-12-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥211.8bn2022-01-01 → 2022-12-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥228.9bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥161.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥265.8bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥190.5bn2023-01-01 → 2023-12-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥81.6bn2022-01-01 → 2022-12-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥95.3bn2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥137.3bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥189.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.3bn2023-01-01 → 2023-12-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥95.5bn2022-01-01 → 2022-12-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥95.8bn2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥685.062025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥633.762024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥224.12023-01-01 → 2023-12-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥246.82022-01-01 → 2022-12-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥231.322021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥246.782022-01-01 → 2022-12-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥231.152021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥5,743.73at 2025-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥5,089.58at 2024-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,410.8at 2023-12-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,100.84at 2022-12-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,707.64at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio72.3%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.1%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.2%at 2023-12-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.7%at 2022-12-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.3%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE12.6%2025-01-01 → 2025-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE13.4%2024-01-01 → 2024-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE5.3%2023-01-01 → 2023-12-31vCons.Rate of return on equity IFRS (5-year summary)
ROE6.3%2022-01-01 → 2022-12-31vCons.Rate of return on equity IFRS (5-year summary)
ROE6.5%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees37,758at 2025-12-31Cons.Number of employees
Employees35,338at 2024-12-31Cons.Number of employees
Employees34,388at 2023-12-31vCons.Number of employees
Employees33,482at 2022-12-31vCons.Number of employees
Employees33,226at 2021-12-31dCons.Number of employees
Revenue¥98.8bn2025-01-01 → 2025-12-31StandaloneOperating revenue1
Revenue¥118.0bn2024-01-01 → 2024-12-31StandaloneOperating revenue1
Revenue¥82.4bn2023-01-01 → 2023-12-31vStandaloneOperating revenue1 (5-year summary)
Revenue¥57.0bn2022-01-01 → 2022-12-31vStandaloneOperating revenue1 (5-year summary)
Revenue¥115.0bn2021-01-01 → 2021-12-31dStandaloneOperating revenue1 (5-year summary)
Operating income¥82.7bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income¥102.9bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income¥84.2bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income¥105.0bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥70.0bn2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥46.4bn2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥104.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥88.4bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax¥105.0bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income¥89.9bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income¥106.4bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥71.0bn2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income¥47.4bn2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income¥106.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.32Tat 2025-12-31StandaloneAssets
Total assets¥1.38Tat 2024-12-31StandaloneAssets
Total assets¥1.21Tat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥1.27Tat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥1.25Tat 2021-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥298.8bnat 2025-12-31StandaloneLiabilities
Total liabilities¥309.6bnat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.03Tat 2025-12-31StandaloneNet assets
Net assets / equity¥1.07Tat 2024-12-31StandaloneNet assets
Net assets / equity¥1.08Tat 2023-12-31vStandaloneNet assets
Net assets / equity¥1.06Tat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥1.07Tat 2021-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥101.5bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥130.4bnat 2024-12-31StandaloneCash and deposits
EPS (basic)¥169.522025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥196.522024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥130.922023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.372022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥195.52021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥1402025-01-01 → 2025-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1202024-01-01 → 2024-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1102023-01-01 → 2023-12-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1002021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,941.14at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,997.67at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,989.83at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥1,959.51at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥1,970.44at 2021-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.4%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.6%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.1%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio85.6%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.6%2025-01-01 → 2025-12-31StandaloneRate of return on equity (5-year summary)
ROE9.9%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE6.6%2023-01-01 → 2023-12-31vStandaloneRate of return on equity (5-year summary)
ROE4.4%2022-01-01 → 2022-12-31vStandaloneRate of return on equity (5-year summary)
ROE10.2%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued542,988,917at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued552,024,717at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued557,835,617at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued557,835,617at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued557,835,617at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees224at 2025-12-31StandaloneNumber of employees
Employees183at 2024-12-31StandaloneNumber of employees
Employees151at 2023-12-31vStandaloneNumber of employees
Employees147at 2022-12-31vStandaloneNumber of employees
Employees137at 2021-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2025-01-01 → 2025-12-31¥9.0bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-12-31−¥3.6bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-12-31−¥3.6bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-12-31−¥56.8bn
Consumer Productsreportable segmentcapex2025-01-01 → 2025-12-31¥5.1bn
Consumer Productsreportable segmentemployeesat 2025-12-31590 pure
Consumer Productsreportable segmentrevenue2025-01-01 → 2025-12-31¥34.6bn
Consumer Productsreportable segmentrevenue external2025-01-01 → 2025-12-31¥34.6bn
Consumer Productsreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥24m
Consumer Productsreportable segmentsegment profit2025-01-01 → 2025-12-31¥25.1bn
Nutraceuticalsreportable segmentcapex2025-01-01 → 2025-12-31¥38.9bn
Nutraceuticalsreportable segmentemployeesat 2025-12-319625 pure
Nutraceuticalsreportable segmentrevenue2025-01-01 → 2025-12-31¥577.7bn
Nutraceuticalsreportable segmentrevenue external2025-01-01 → 2025-12-31¥577.6bn
Nutraceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥48m
Nutraceuticalsreportable segmentsegment profit2025-01-01 → 2025-12-31¥57.7bn
Otherreportable segmentcapex2025-01-01 → 2025-12-31¥17.6bn
Otherreportable segmentemployeesat 2025-12-313143 pure
Otherreportable segmentrevenue2025-01-01 → 2025-12-31¥115.9bn
Otherreportable segmentrevenue external2025-01-01 → 2025-12-31¥112.4bn
Otherreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥3.5bn
Otherreportable segmentsegment profit2025-01-01 → 2025-12-31¥8.0bn
Pharmaceuticalsreportable segmentcapex2025-01-01 → 2025-12-31¥221.7bn
Pharmaceuticalsreportable segmentemployeesat 2025-12-3122897 pure
Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-12-31¥1.74T
Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-12-31¥1.74T
Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-12-31¥445.3bn
—segment totalcapex2025-01-01 → 2025-12-31¥283.3bn
—segment totalemployeesat 2025-12-3136255 pure
—segment totalrevenue2025-01-01 → 2025-12-31¥2.47T
—segment totalrevenue external2025-01-01 → 2025-12-31¥2.47T
—segment totalrevenue intersegment2025-01-01 → 2025-12-31¥3.6bn
—segment totalsegment profit2025-01-01 → 2025-12-31¥536.2bn
Reconciling Itemsreconcilingcapex2024-01-01 → 2024-12-31¥9.9bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-12-31−¥3.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-12-31−¥3.6bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-12-31−¥51.8bn
Consumer Productsreportable segmentcapex2024-01-01 → 2024-12-31¥3.6bn
Consumer Productsreportable segmentrevenue2024-01-01 → 2024-12-31¥33.8bn
Consumer Productsreportable segmentrevenue external2024-01-01 → 2024-12-31¥33.8bn
Consumer Productsreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥7m
Consumer Productsreportable segmentsegment profit2024-01-01 → 2024-12-31¥23.0bn
Nutraceuticalsreportable segmentcapex2024-01-01 → 2024-12-31¥54.2bn
Nutraceuticalsreportable segmentrevenue2024-01-01 → 2024-12-31¥557.0bn
Nutraceuticalsreportable segmentrevenue external2024-01-01 → 2024-12-31¥557.0bn
Nutraceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥37m
Nutraceuticalsreportable segmentsegment profit2024-01-01 → 2024-12-31¥59.8bn
Otherreportable segmentcapex2024-01-01 → 2024-12-31¥7.7bn
Otherreportable segmentrevenue2024-01-01 → 2024-12-31¥113.7bn
Otherreportable segmentrevenue external2024-01-01 → 2024-12-31¥110.1bn
Otherreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥3.6bn
Otherreportable segmentsegment profit2024-01-01 → 2024-12-31¥7.5bn
Pharmaceuticalsreportable segmentcapex2024-01-01 → 2024-12-31¥252.0bn
Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-12-31¥1.63T
Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-12-31¥1.63T
Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-12-31¥285.1bn
—segment totalcapex2024-01-01 → 2024-12-31¥317.4bn
—segment totalrevenue2024-01-01 → 2024-12-31¥2.33T
—segment totalrevenue external2024-01-01 → 2024-12-31¥2.33T
—segment totalrevenue intersegment2024-01-01 → 2024-12-31¥3.6bn
—segment totalsegment profit2024-01-01 → 2024-12-31¥375.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,288
ItemContextValueUnit
Loss on sale of fixed assets IFRSCurrentYearDuration47000000JPY
Loss on retirement of fixed assets IFRSPrior1YearDuration704000000JPY
Loss on retirement of fixed assets IFRSCurrentYearDuration1720000000JPY
Change in fair value of contingent considerations expense IFRSPrior1YearDuration1486000000JPY
Change in fair value of contingent considerations expense IFRSCurrentYearDuration-JPY
Other other expenses IFRSPrior1YearDuration1540000000JPY
Other other expenses IFRSCurrentYearDuration1800000000JPY
Other expenses IFRSPrior1YearDuration3889000000JPY
Other expenses IFRSCurrentYearDuration3568000000JPY
Financial assets measured at amortized cost interest income IFRSPrior1YearDuration7479000000JPY
Financial assets measured at amortized cost interest income IFRSCurrentYearDuration7265000000JPY
Financial assets measured at fair value through other comprehensive income dividend income IFRSPrior1YearDuration2401000000JPY
Financial assets measured at fair value through other comprehensive income dividend income IFRSCurrentYearDuration2527000000JPY
Financial assets measured at fair value through profit or loss dividend income IFRSPrior1YearDuration-JPY
Financial assets measured at fair value through profit or loss dividend income IFRSCurrentYearDuration23000000JPY
Gain on financial assets and liabilities measured at fair value through profit or loss gain on change in fair value IFRSPrior1YearDuration2107000000JPY
Gain on financial assets and liabilities measured at fair value through profit or loss gain on change in fair value IFRSCurrentYearDuration4906000000JPY
Foreign exchange gain IFRSPrior1YearDuration8679000000JPY
Foreign exchange gain IFRSCurrentYearDuration-JPY
Other finance income IFRSPrior1YearDuration412000000JPY
Other finance income IFRSCurrentYearDuration972000000JPY
Finance income IFRSPrior1YearDuration21081000000JPY
Finance income IFRSCurrentYearDuration15695000000JPY
Financial liabilities measured at amortized cost interest expenses IFRSPrior1YearDuration4041000000JPY
Financial liabilities measured at amortized cost interest expenses IFRSCurrentYearDuration1792000000JPY
Lease obligations interest expenses IFRSPrior1YearDuration2141000000JPY
Lease obligations interest expenses IFRSCurrentYearDuration2446000000JPY
Loss on financial assets and liabilities measured at fair value through profit or loss loss on change in fair value IFRSPrior1YearDuration1659000000JPY
Loss on financial assets and liabilities measured at fair value through profit or loss loss on change in fair value IFRSCurrentYearDuration7894000000JPY
Foreign exchange loss IFRSPrior1YearDuration-JPY
Foreign exchange loss IFRSCurrentYearDuration11957000000JPY
Other finance costs IFRSPrior1YearDuration948000000JPY
Other finance costs IFRSCurrentYearDuration2943000000JPY
Finance costs IFRSPrior1YearDuration8791000000JPY
Finance costs IFRSCurrentYearDuration27033000000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember130375000000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember101507000000JPY
Lease investment assets caPrior1YearInstant_NonConsolidatedMember230000000JPY
Lease investment assets caCurrentYearInstant_NonConsolidatedMember230000000JPY
SuppliesPrior1YearInstant_NonConsolidatedMember77000000JPY
SuppliesCurrentYearInstant_NonConsolidatedMember-JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember3406000000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember3182000000JPY
Short term loans receivable to subsidiaries and affiliatesPrior1YearInstant_NonConsolidatedMember142622000000JPY
Short term loans receivable to subsidiaries and affiliatesCurrentYearInstant_NonConsolidatedMember121927000000JPY
Income taxes receivablePrior1YearInstant_NonConsolidatedMember146000000JPY
Income taxes receivableCurrentYearInstant_NonConsolidatedMember239000000JPY
Other caPrior1YearInstant_NonConsolidatedMember10255000000JPY
Other caCurrentYearInstant_NonConsolidatedMember6555000000JPY
Allowance for doubtful accounts caPrior1YearInstant_NonConsolidatedMember-1323000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass